BioAlliance Pharma SA
BioAlliance Pharma SA: Consolidated Accounts for the First Half of 2009
Published in Medical Letter on the CDC and FDA, September 13th, 2009
Regulatory News: Loramyc® sales triple submission of a marketing authorization application for Setofilm® in Europe submission of a new drug application for Loramyc® in the USA significant progress in the supportive care portfolio OSEO funding validates the company's innovations BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today presented its consolidated half-year accounts to June 30, 2009.
Consolidated accounts (Normes IFRS) in thousands of euros
30/06/2009
30/06/2008
Revenues 4 145 4 896...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- US Army Medical Research Institute of Infectious Diseases
Single host gene may hold key to treating both ebola and anthrax infections - Alcoholism
Research reports from Duke University provide new insights into alcoholism - Bioengineering
ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis - Chronic Obstructive Pulmonary Disease
Four Studies Published in the Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations - Depression
New depression research from University of Leicester discussed - Diabetes
Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
